The clinical utility of the Ca19-9 radioimmunoassay for the diagnosis of pancreatic cancer presenting as pain or weight loss. A cost-effectiveness analysis (Q41222106)
Jump to navigation
Jump to search
scientific article published on October 1989
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The clinical utility of the Ca19-9 radioimmunoassay for the diagnosis of pancreatic cancer presenting as pain or weight loss. A cost-effectiveness analysis |
scientific article published on October 1989 |
Statements
1 reference
The clinical utility of the Ca19-9 radioimmunoassay for the diagnosis of pancreatic cancer presenting as pain or weight loss. A cost-effectiveness analysis (English)
1 reference
Richter JM
1 reference
Christensen MR
1 reference
Rustgi AK
1 reference
Silverstein MD
1 reference
1 October 1989
1 reference
1 reference
Identifiers
1 reference